8-K - Palvella Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement On February 25, 2026, Palvella Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underw

Material Agreement

$125.00$187.3M

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated February 25, 2026, by and among Palvella Therapeutics,

Exhibits Only

Exhibits (3)

1.1

EXHIBIT 1.1

5.1

EXHIBIT 5.1

8-K

FORM 8-K